Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine)

Ram I Mahato, Shigeo Takemura, Ken Akamatsu, Makiya Nishikawa, Yoshinobu Takakura, Mitsuru Hashida

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

The disposition characteristics of a 20 mer antisense phosphodiester oligonucleotide (PO) and its fully phosphorothioated derivative (PS) alone or complexed with glycosylated poly(L-lysine) (galactosylated polylysine, Gal-PLL: mannosylated polylysine, Man-PLL) were studied in mice in relation to their physicochemical characteristics. Good complex formation was obtained at a ratio of 1:0.6, w/w [oligonucleotides (ODNs)/carrier]. The 1:0.6 weight ratio of ODNs/Gal-PLL and ODNs/Man-PLL complexes had ζ potentials of -27 to -31 mV and mean particle size of 100 to 160 nm. After intravenous injection, 35S-labeled ODNs were eliminated rapidly from the circulation: however, their organ disposition characteristics depended on their type. Complex formation with glycosylated PLL increased the hepatic uptake and decreased the urinary clearance of these ODNs to a great extent. These complexes were taken up by both liver parenchymal cells (PC) and nonparenchymal cells (NPC). However, ODNs/Gal-PLL complexes showed a fairly high PC concentration, whereas ODNs/Man-PLL complexes distributed equally to both PC and NPC. The hepatic uptakes of PS/Gal-PLL and PS/Man-PLL complexes were partially inhibited by prior administration of Gal-BSA and Man-BSA, respectively, suggesting their hepatic uptake via the respective receptor-mediated endocytosis. However, uptake by galactose receptors of Kupffer cells, ζ potential, particle size, and Kupffer cell phagocytosis also seem to influence their uptake process. In conclusion, this study illustrates that CDNs can be delivered to hepatocytes and macrophages via galactose and mannose receptors, respectively.

Original languageEnglish (US)
Pages (from-to)887-895
Number of pages9
JournalBiochemical Pharmacology
Volume53
Issue number6
DOIs
StatePublished - Mar 21 1997

Fingerprint

Antisense Oligonucleotides
Phase locked loops
Lysine
Polylysine
Kupffer Cells
Liver
Particle Size
Cytophagocytosis
Derivatives
Oligonucleotides
Endocytosis
Intravenous Injections
Hepatocytes
Particle size
Macrophages
Weights and Measures
galactose receptor

Keywords

  • hepatic uptake
  • macrophage
  • oligonucleotides
  • particle size
  • pharmacokinetics
  • zeta potential

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). / Mahato, Ram I; Takemura, Shigeo; Akamatsu, Ken; Nishikawa, Makiya; Takakura, Yoshinobu; Hashida, Mitsuru.

In: Biochemical Pharmacology, Vol. 53, No. 6, 21.03.1997, p. 887-895.

Research output: Contribution to journalArticle

Mahato, Ram I ; Takemura, Shigeo ; Akamatsu, Ken ; Nishikawa, Makiya ; Takakura, Yoshinobu ; Hashida, Mitsuru. / Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). In: Biochemical Pharmacology. 1997 ; Vol. 53, No. 6. pp. 887-895.
@article{37b4e39fd1e0417b856eb03b7c4fa1bb,
title = "Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine)",
abstract = "The disposition characteristics of a 20 mer antisense phosphodiester oligonucleotide (PO) and its fully phosphorothioated derivative (PS) alone or complexed with glycosylated poly(L-lysine) (galactosylated polylysine, Gal-PLL: mannosylated polylysine, Man-PLL) were studied in mice in relation to their physicochemical characteristics. Good complex formation was obtained at a ratio of 1:0.6, w/w [oligonucleotides (ODNs)/carrier]. The 1:0.6 weight ratio of ODNs/Gal-PLL and ODNs/Man-PLL complexes had ζ potentials of -27 to -31 mV and mean particle size of 100 to 160 nm. After intravenous injection, 35S-labeled ODNs were eliminated rapidly from the circulation: however, their organ disposition characteristics depended on their type. Complex formation with glycosylated PLL increased the hepatic uptake and decreased the urinary clearance of these ODNs to a great extent. These complexes were taken up by both liver parenchymal cells (PC) and nonparenchymal cells (NPC). However, ODNs/Gal-PLL complexes showed a fairly high PC concentration, whereas ODNs/Man-PLL complexes distributed equally to both PC and NPC. The hepatic uptakes of PS/Gal-PLL and PS/Man-PLL complexes were partially inhibited by prior administration of Gal-BSA and Man-BSA, respectively, suggesting their hepatic uptake via the respective receptor-mediated endocytosis. However, uptake by galactose receptors of Kupffer cells, ζ potential, particle size, and Kupffer cell phagocytosis also seem to influence their uptake process. In conclusion, this study illustrates that CDNs can be delivered to hepatocytes and macrophages via galactose and mannose receptors, respectively.",
keywords = "hepatic uptake, macrophage, oligonucleotides, particle size, pharmacokinetics, zeta potential",
author = "Mahato, {Ram I} and Shigeo Takemura and Ken Akamatsu and Makiya Nishikawa and Yoshinobu Takakura and Mitsuru Hashida",
year = "1997",
month = "3",
day = "21",
doi = "10.1016/S0006-2952(96)00880-5",
language = "English (US)",
volume = "53",
pages = "887--895",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine)

AU - Mahato, Ram I

AU - Takemura, Shigeo

AU - Akamatsu, Ken

AU - Nishikawa, Makiya

AU - Takakura, Yoshinobu

AU - Hashida, Mitsuru

PY - 1997/3/21

Y1 - 1997/3/21

N2 - The disposition characteristics of a 20 mer antisense phosphodiester oligonucleotide (PO) and its fully phosphorothioated derivative (PS) alone or complexed with glycosylated poly(L-lysine) (galactosylated polylysine, Gal-PLL: mannosylated polylysine, Man-PLL) were studied in mice in relation to their physicochemical characteristics. Good complex formation was obtained at a ratio of 1:0.6, w/w [oligonucleotides (ODNs)/carrier]. The 1:0.6 weight ratio of ODNs/Gal-PLL and ODNs/Man-PLL complexes had ζ potentials of -27 to -31 mV and mean particle size of 100 to 160 nm. After intravenous injection, 35S-labeled ODNs were eliminated rapidly from the circulation: however, their organ disposition characteristics depended on their type. Complex formation with glycosylated PLL increased the hepatic uptake and decreased the urinary clearance of these ODNs to a great extent. These complexes were taken up by both liver parenchymal cells (PC) and nonparenchymal cells (NPC). However, ODNs/Gal-PLL complexes showed a fairly high PC concentration, whereas ODNs/Man-PLL complexes distributed equally to both PC and NPC. The hepatic uptakes of PS/Gal-PLL and PS/Man-PLL complexes were partially inhibited by prior administration of Gal-BSA and Man-BSA, respectively, suggesting their hepatic uptake via the respective receptor-mediated endocytosis. However, uptake by galactose receptors of Kupffer cells, ζ potential, particle size, and Kupffer cell phagocytosis also seem to influence their uptake process. In conclusion, this study illustrates that CDNs can be delivered to hepatocytes and macrophages via galactose and mannose receptors, respectively.

AB - The disposition characteristics of a 20 mer antisense phosphodiester oligonucleotide (PO) and its fully phosphorothioated derivative (PS) alone or complexed with glycosylated poly(L-lysine) (galactosylated polylysine, Gal-PLL: mannosylated polylysine, Man-PLL) were studied in mice in relation to their physicochemical characteristics. Good complex formation was obtained at a ratio of 1:0.6, w/w [oligonucleotides (ODNs)/carrier]. The 1:0.6 weight ratio of ODNs/Gal-PLL and ODNs/Man-PLL complexes had ζ potentials of -27 to -31 mV and mean particle size of 100 to 160 nm. After intravenous injection, 35S-labeled ODNs were eliminated rapidly from the circulation: however, their organ disposition characteristics depended on their type. Complex formation with glycosylated PLL increased the hepatic uptake and decreased the urinary clearance of these ODNs to a great extent. These complexes were taken up by both liver parenchymal cells (PC) and nonparenchymal cells (NPC). However, ODNs/Gal-PLL complexes showed a fairly high PC concentration, whereas ODNs/Man-PLL complexes distributed equally to both PC and NPC. The hepatic uptakes of PS/Gal-PLL and PS/Man-PLL complexes were partially inhibited by prior administration of Gal-BSA and Man-BSA, respectively, suggesting their hepatic uptake via the respective receptor-mediated endocytosis. However, uptake by galactose receptors of Kupffer cells, ζ potential, particle size, and Kupffer cell phagocytosis also seem to influence their uptake process. In conclusion, this study illustrates that CDNs can be delivered to hepatocytes and macrophages via galactose and mannose receptors, respectively.

KW - hepatic uptake

KW - macrophage

KW - oligonucleotides

KW - particle size

KW - pharmacokinetics

KW - zeta potential

UR - http://www.scopus.com/inward/record.url?scp=0030907837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030907837&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(96)00880-5

DO - 10.1016/S0006-2952(96)00880-5

M3 - Article

VL - 53

SP - 887

EP - 895

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 6

ER -